Zoliflodacin
- Generic Name
- Zoliflodacin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C22H22FN5O7
- CAS Number
- 1620458-09-4
- Unique Ingredient Identifier
- FWL2263R77
- Background
Zoliflodacin has been used in trials studying the basic science and treatment of Gonorrhoea.
- Associated Conditions
- -
- Associated Therapies
- -
India's 'blockbuster' drugs to take on antibiotics-resistant superbugs
India's new drugs aim to combat antibiotic-resistant superbugs, with Enmetazobactam and Zaynich showing promise. Antibiotic resistance caused 1.14 million deaths globally in 2021, with India facing significant challenges. Innovative drugs and better prescription practices are crucial to address this growing threat.
Investigational Antibiotic Shows Efficacy, Safety in Late Stage Trial for Uncomplicated Gonorrhea
STIs, including multidrug-resistant gonorrhea, are increasing in the US, prompting the need for new therapies. Zoliflodacin, an oral single-dose antibiotic, showed efficacy and safety in late-stage trials, with plans for FDA approval in Q1 2025.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath